SkyAI (SKYA) Q3 2026 earnings summary

Executive summary

• Q3 net income was $84.9M, driven primarily by a $90.5M unrealized gain on SOL; 9M net loss was $24.6M, including $17.5M of realized digital-asset losses.

• Strategy shifted from legacy medical-device operations and a SOL treasury toward development of an AI-enabled agentic finance platform, with Hong Kong established as the international operational headquarters.

Financial highlights

• Q3 net income was $84.9M vs. a $105.3M loss YoY; 9M net loss was $24.6M vs. $99.8M YoY.

• Q3 net revenue was $0 vs. $68,040 YoY; 9M revenue was $192,780 vs. $204,120, with a $294,026 gross loss after a $284,228 inventory reserve.

• Q3 net staking revenue was $2.55M; 9M was $8.01M. 9M SG&A was $12.81M and R&D was $1.05M.

• September 30 cash was $7.48M; total assets were $243.95M, including $231.43M of SOL at fair value, and stockholders’ equity was $241.16M.

Outlook and guidance

• Following the October SOL sale, focus is on developing the agentic finance platform; management expects an additional ~$16M loss in Q4 from the sale.

• Future AI development, commercialization and working capital are expected to be funded through equity and/or traditional financing until operations can fund requirements; no SOL repurchases are planned after the tender offer.

• Results for the nine months are not necessarily indicative of FY 2026 results.